Skip to main content
All CollectionsProductsMonoatomics
How are your Liquid Monatomics procured?
How are your Liquid Monatomics procured?
Updated over a week ago

To understand the answers to these questions the reader must first be familiar with the methods in which monatomics can be obtained. The most common method for the extraction of pseudo-monatomic elements which are generally in (diatomic form) is based upon the methods of David R. Hudson. This method is a destructive hydrochloric acid reaction (aqua regia) on metallic gold and subsequent chemical purifications. The chlorinated Au and Na complexes are then treated by annealing. The m-state elements are then separated with specific differentiation chemical processes.

Other related methods start from other ores such as Azomite, clay, and even organic matter that is dissolved in HCl or other aggressive reagents and then selectively precipitated. The same method is used for all processes involving ocean water and sea salts that use acid/base reactions performed according to the philosophy of Hudson’s so-called “wet way” and “dry way”. In these processes, the main active compound is NaOH or other lye mixes used as precipitants. This gives rise to abundant sedimentation of Mg and Ca complex salts. The pseudo-monatomic elements chemically graft to the salts but as a denser diatomic form.

Our process is totally different, applying a proprietary technology based on true monatomic element extraction. First, a high energy plasma cloud is created by laser volatilization of 99.9999% gold pellets enriched with a blend of specific minerals (CEPP Method). This dense ionic cloud is composed of heterogeneous and complex m-state matter. Next, the cloud is subjected to a process of selective separation and purification called the Matrix Replacement Process (MRP) which is conducted by means of two modified 70 MeV accelerators. Once isolated, the monatomic elements are included (in differentiated or singular clusters) in a monatomic capsid by means of a modified high-energy ion implantation system. Finally, this monatomic concentrate will be dosed into bioavailable recipients (USP-W) for consumers.

*These statements have not been approved by the Food and Drug Administration and should not be treated as professional medical advice

Did this answer your question?